The Global Disease Control and Prevention Vaccine Market size is expected to grow at a CAGR of 8.2% during the forecast period, by 2020, it is projected to reach USD 27.3 billion in value. The growth will primarily be driven by increasing demand for vaccines owing to factors such as changing lifestyle patterns, rise in awareness about diseases, and efforts from governments across the globe to prevent them through vaccination programs and campaigns.
Disease Control and Prevention Vaccines are vaccines used to prevent diseases that can be transmitted from person to person, animal or plant. These vaccines prevent or reduce the severity of an illness. The Disease Control and Prevention vaccines market aims to reduce population morbidity, mortality, disability by controlling infectious diseases such as hepatitis A&B, tetanus, influenza, etc.
On the basis of Types, the market is segmented into Live-Attenuated, Inactivated, and Recombinant Sub Units.
Live-attenuated vaccines are live viruses that have been weakened so they cannot cause infection in humans. The vaccine virus replicates inside the body but does not produce enough of itself to overcome immunity and lead to disease. Live-attenuated vaccines can be given orally (e.g., measles) or by injection (e.g., polio).
Inactivated Vaccines are usually made of whole killed virus and bacteria. They will not cause infection to the vaccinated person as they have been weakened or have no active substances that can stimulate an immune response in the human body. In general, these vaccines cannot be injected into people who have a weak immune system because they may lead to severe infection.
A Recombinant Sub Unit Vaccine is a vaccine composed of recombinant protein subunits. They are used as immunizing agents in the prevention and treatment of diseases caused by bacteria, viruses, or parasites. The proteins that they contain are derived from either natural sources (such as pathogenic organisms) or genetically engineered cells lines. These vaccines can be classified into two types: live attenuated and killed whole cells/subunit preparations.
On the basis of Application, the market is segmented into Pediatric Vaccines and Adult Vaccines.
Disease Control and Prevention Vaccines are used as preventative measures for children against infectious diseases. They aim to immunize, protect and support the health of an individual by providing immunity from illness that can be transmitted through contact with other infected individuals or animals. Disease control vaccines also have a therapeutic effect in cases where prevention is not possible, such as post-exposure or in certain situations like natural disasters.
Disease Control and Prevention Vaccines in Adult Vaccines are used to protect individuals who may be at risk of contracting specific diseases. These vaccines prevent the contraction of these infectious agents by either inducing immunity or preventing them from attacking healthy cells, tissues, and organ systems.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The Latin American market is also predicted to register significant gains. The increasing number of Zika virus cases has been driving demand for vaccines that can protect against this infection which may be transmitted via mosquitoes. Countries across the region have seen an increase in birth defects due to pregnant women being exposed to infections like the Tdap vaccine etc., leading them towards higher vaccination coverage through booster doses and other complementary vaccines.
Up Market Research published a new report titled “Disease Control and Prevention Vaccine Market research report which is segmented by Types (Live-Attenuated, Inactivated, Recombinant Sub Unit, and Toxoid), By Applications (Pediatric Vaccine, Adult Vaccine), By Players/Companies GSK, Merck & Co., Inc, Pfizer, Sanofi, AstraZeneca PLC, Sinovac Biotech Ltd, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd, Daiichi Sankyo”.
|Report Attributes||Report Details|
|Report Title||Disease Control and Prevention Vaccine Market Research Report|
|By Type||Live-Attenuated, Inactivated, Recombinant Sub Unit and Toxoid|
|By Application||Pediatric Vaccine, Adult Vaccine|
|By Companies||GSK, Merck & Co., Inc, Pfizer, Sanofi, AstraZeneca PLC, Sinovac Biotech Ltd, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd, Daiichi Sankyo|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||216|
|Number of Tables & Figures||152|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Live-Attenuated, Inactivated, Recombinant Sub Unit and Toxoid and By Application Pediatric Vaccine, Adult Vaccine.
Some of the companies that are profiled in this report are:
Disease Control and Prevention Vaccine Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Disease Control and Prevention Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Disease Control and Prevention Vaccine Market Report:
Some other reports from this category!